Fund the Future supports cancer research.
The pandemic has unfortunately impacted ACS’ ability to save lives. Dollars being raised are way down, and the truth is, CANCER HASN’T STOPPED SO NEITHER CAN WE. While communities were shut down, cancer gained ground. That means we are working harder than ever to help cancer patients.
SPECIFICALLY, WHAT IS AT RISK?
For the first time in the history of the American Cancer Society – OUR MISSION TO SAVE LIVES THROUGH CANCER RESEARCH IS AT RISK.
WHAT DO THESE DEEP CUTS IN FUNDING MEAN?
· A generation of cancer research lost.
· A lack of available funding could deter young investigators with big ideas from the cancer research field.
· And, for cancer patients this may dramatically alter the availability of lifesaving treatments.
DID YOU KNOW?
· ACS is the largest, primary private nonprofit funder of cancer research.
· Since 1946, ACS has invested more than $4.9 billion in research spanning numerous areas, including how best to prevent and treat cancer, why and how cancer comes about, what cancer survivors need most, and how to ensure equal access to cancer care.
· ACS has played a role in almost every major cancer research breakthrough in the last century and have funded the research of 49 investigators who went on to win the Nobel Prize.
· Our rigorous peer-review process is top notch, and we have reach into over 200 institutions nationwide - which allows us to invest in the very best research projects.
· About 68% of the directors of National Cancer Institute-designated cancer centers are former American Cancer Society grantees.
· Every year, since 1951, American Cancer Society researchers have published Cancer Facts & Figures, the definitive source for projections of the number of cancer cases and deaths expected in each state and in the nation in the current year.